http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102293743-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fb117a460191c60397dfeb1c84b12b2b |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-145 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-295 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39 |
| filingDate | 2010-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c098a1e5d77795bea3f06e8bcaa22f27 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_428754341322d027c88d2cbca3262a74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_262ef6d74eb31ce33f21bb6fd5d2a843 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3277e6e03956a7d0c670a52410da8f45 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c873ca176ffe248b5c0ffc7abe913a4d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ed379addb8be48019eae8377e7a72ae http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95121e667297f53ceb7a4816c224a763 |
| publicationDate | 2013-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102293743-B |
| titleOfInvention | Lipid microsphere composition |
| abstract | The invention relates to a lipid microsphere composition. The lipid microsphere composition is characterized by comprising a lipid microsphere emulsifying agent and an immunogenic composition, wherein the lipid microsphere emulsifying agent comprises 1 to 30 weight percent of pharmaceutical grade grease, 0.1 to 10 weight percent of zwitterionic/non-ionic surfactant composition, 0.01 to 5 weight percent of stabilizing agent and the balance of aqueous solution; and the immunogenic composition is a univalent to multivalent composition and usually a trivalent composition, and contains a virus antigen or antigenic preparation from one or more pandemic influenza epidemic related influenza virus strains or with one or more pandemic influenza epidemic related influenza virus strains. The lipid microsphere composition not only can serve as an excellent aid of a vaccine, but also can serve as a conveying system of the vaccine. The lipid microsphere composition is applicable to different administration routes of the vaccine, improves compliance, diversity and selectivity of clinical application, and achieves wide, safe and effective immune effect. |
| priorityDate | 2010-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 381.